EMI (Encore Medical) Total Equity: $-1.67 Mil (As of Dec. 2025)


What is Encore Medical Total Equity?

Encore Medical EMI Total Equity is $-1.67 Mil as of Dec. 2025.

Encore Medical's total equity for the quarter that ended in Dec. 2025 was $-1.67 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Encore Medical Total Equity Historical Data

* Premium members only.

The historical data trend for Encore Medical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encore Medical Total Equity Chart

Encore Medical Annual Data
Trend Dec23 Dec24 Dec25
Total Equity
-0.16 -0.91 -1.67

Encore Medical Quarterly Data
Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial 0.00 -0.91 -0.99 -1.30 -1.67

Encore Medical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Encore Medical's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2.16-3.83
=-1.67

Encore Medical's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2.16-3.83
=-1.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-1.67 Mil mean?
Encore Medical (EMI) has a Total Equity of $-1.67 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Encore Medical and its competitors.
Is Encore Medical's Total Equity too high?
Encore Medical's current Total Equity is $-1.67 Mil.
How does Encore Medical's Total Equity compare to ?
Encore Medical's Total Equity of $-1.67 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Encore Medical and its competitors. Encore Medical's current Total Equity is $-1.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encore Medical stock overvalued right now?
Encore Medical (EMI) has a current Total Equity of $-1.67 Mil. The current Total Equity is $-1.67 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Encore Medical (EMI), the current Total Equity is $-1.67 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Encore Medical Business Description

Comparable Companies
Address 2975 Lone Oak Drive, Suite 140, Eagan, MN, USA, 55121
Encore Medical Inc develops, manufactures, and markets septal occlusion devices for the repair of certain cardiac defects. Its products have been implanted in approximately 35,000 patients outside the United States. Its closure device is designed to correct a cardiac defect, generally diagnosed in adulthood, known as a patent foramen ovale (PFO). The company also currently market and sell septal occlusion devices for the transcatheter closure of atrial septal defects (ASD).